查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1463101

孟魯司特鈉市場、佔有率、規模、趨勢、產業分析報告：依產品類型、劑型、應用、地區、細分市場預測，2024-2032

Montelukast Sodium Market Share, Size, Trends, Industry Analysis Report, By Product Type (Montelukast Sodium Amorphous and Montelukast Sodium Crystalline); By Dosage Form; By Application; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，預計到2032年，全球孟魯司特鈉市場規模將達到7.7378億美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

由於促進其擴張的幾個關鍵因素，孟魯司特鈉市場呈現穩定成長。 孟魯司特鈉是一種白三烯受體拮抗劑，主要用於控制和預防氣喘症狀以及緩解過敏性鼻炎症狀。 它對這些症狀的有效性為全球市場的擴張做出了重大貢獻。 此外，全球氣喘和過敏性鼻炎盛行率的上升也刺激了對孟魯司特鈉的需求。 隨著醫療保健意識的提高和診斷能力的提高，越來越多的人被診斷出患有這些疾病，進一步推動了市場的成長。

此外，製藥公司專注於研發活動以擴大孟魯司特鈉的應用也是市場成長的主要推動力。 這些努力旨在探索其他呼吸系統疾病的潛在治療方法，例如運動引起的支氣管收縮和慢性阻塞性肺病（COPD），從而擴大市場基礎。 此外，孟魯司特鈉的安全性和有效性使其越來越多地在兒科人群中採用，進一步推動了市場擴張。

此外，各地區對孟魯司特鈉製劑的監管批准不斷增加，也推動了孟魯司特鈉的採用並有助於市場擴張。 孟魯司特鈉仿製藥的出現在提高市場滲透率方面也發揮著重要作用，特別是在負擔能力和可及性成為關鍵問題的新興市場。

區域分析顯示，北美目前佔孟魯司特鈉市場的主要佔有率，這主要是由於該地區氣喘和過敏性鼻炎的高盛行率以及完善的醫療基礎設施的存在。 然而，預計亞太地區在預測期內將呈現巨大的成長機會。 中國和印度等國家的醫療成本上升、人們對呼吸系統疾病的認識不斷提高以及患者人數不斷增加等因素預計將推動該地區的市場成長。

孟魯司特鈉市場報告亮點

孟魯司特鈉無定形片段在2023年佔最大佔有率，廣泛用於預防呼吸系統疾病。

片劑細分市場在 2023 年佔最大佔有率，因為它具有易於運輸、劑量準確和污染機會較小等許多優點。

由於全球氣喘盛行率不斷上升以及人們對可用治療方案的認識不斷提高，氣喘細分市場將在 2023 年引領市場。

由於呼吸道疾病盛行率上升以及發現新應用的研究活動增加，北美將在 2023 年主導全球市場

主要市場參與者包括 Sandoz International、Sun Pharmaceutical Industries、Merck、Cipla、Aurobindo Pharma 等。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第 4 章孟魯司特鈉全球市場洞察

  • 孟魯司特鈉市場 - 應用概況
  • 孟魯司特鈉市場動態
    • 推動者和機會
      • 人口老化加劇推動市場成長
      • 飲食習慣的變化和快速城市化推動市場成長
    • 抑制因素和課題
      • 與孟魯司特相關的副作用
  • PESTEL 分析
  • 孟魯司特鈉市場應用趨勢
  • 價值鏈分析
  • 新冠肺炎 (COVID-19) 影響分析

第五章以劑型劃分的世界市場

  • 主要發現
  • 簡介
  • 平板電腦
  • 咀嚼片
  • 口服溶液

第 6 章全球市場（依產品類型）

  • 主要發現
  • 簡介
  • 無定形孟魯司特鈉
  • 孟魯司特鈉晶體

第 7 章依應用劃分的世界市場

  • 主要發現
  • 簡介
  • 氣喘
  • 過敏性鼻炎蕁麻疹
  • 其他

第 8 章依地區劃分的世界市場

  • 主要發現
  • 簡介
    • 2019-2032 年孟魯司特鈉市場評估（依地區）
  • 孟魯司特鈉市場 - 北美
    • 北美：孟魯司特鈉市場，依劑型，2019-2032
    • 北美：孟魯司特鈉市場，依應用劃分，2019-2032 年
    • 北美：孟魯司特鈉市場，依產品類型，2019-2032 年
    • 孟魯司特鈉市場 - 美國
    • 孟魯司特鈉市場 - 加拿大
  • 孟魯司特鈉市場 - 歐洲
    • 歐洲：孟魯司特鈉市場，依劑型，2019-2032 年
    • 歐洲：孟魯司特鈉市場，依應用劃分，2019-2032 年
    • 歐洲：孟魯司特鈉市場，依產品類型，2019-2032 年
    • 孟魯司特鈉市場 - 英國
    • 孟魯司特鈉市場－法國
    • 孟魯司特鈉市場－德國
    • 孟魯司特鈉市場 - 義大利
    • 孟魯司特鈉市場－西班牙
    • 孟魯司特鈉市場－荷蘭
    • 孟魯司特鈉市場－俄羅斯
  • 孟魯司特鈉市場－亞太地區
    • 亞太地區：孟魯司特鈉市場，依劑型，2019-2032 年
    • 亞太地區：孟魯司特鈉市場，依應用劃分，2019-2032 年
    • 亞太地區：孟魯司特鈉市場，依產品類型，2019-2032 年
    • 孟魯司特鈉市場－中國
    • 孟魯司特鈉市場－印度
    • 孟魯司特鈉市場 - 馬來西亞
    • 孟魯司特鈉市場-日本
    • 孟魯司特鈉市場-印度尼西亞
    • 孟魯司特鈉市場-韓國
  • 孟魯司特鈉市場－中東和非洲
    • 中東和非洲：孟魯司特鈉市場，依劑型，2019-2032 年
    • 中東和非洲：孟魯司特鈉市場，依應用劃分，2019-2032 年
    • 中東和非洲：2019-2032 年孟魯司特鈉市場（依產品類型）
    • 孟魯司特鈉市場-沙烏地阿拉伯
    • 孟魯司特鈉市場－阿聯酋
    • 孟魯司特鈉市場 - 以色列
    • 孟魯司特鈉市場－南非
  • 孟魯司特鈉市場 - 拉丁美洲
    • 拉丁美洲：孟魯司特鈉市場，依劑型，2019-2032 年
    • 拉丁美洲：孟魯司特鈉市場，依應用劃分，2019-2032 年
    • 拉丁美洲：孟魯司特鈉市場，依產品類型，2019-2032 年
    • 孟魯司特鈉市場 - 墨西哥
    • 孟魯司特鈉市場－巴西
    • 孟魯司特鈉市場-阿根廷

第九章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 合作/協作/合約/出版物

第十章公司簡介

  • Apotex Inc.（Canada）
  • .Aurobindo Pharma Ltd.（India）
  • Cipla Ltd.（India）
  • Glenmark Pharmaceutical Ltd.（India）
  • Jubilant Life Sciences Ltd.（India）
  • Merck & Co. Inc.（US）
  • Mylan N.V.（US）
  • Sandoz International GmbH（Germany）
  • Sun Pharmaceutical Industries Ltd.（India）
  • Teva Pharmaceutical Industries Ltd.（Israel）
Product Code: PM4778

The global montelukast sodium market size is expected to reach USD 773.78 million by 2032, according to a new study by Polaris Market Research. The report "Montelukast Sodium Market Share, Size, Trends, Industry Analysis Report, By Product Type (Montelukast Sodium Amorphous and Montelukast Sodium Crystalline); By Dosage Form; By Application; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Montelukast Sodium market is witnessing steady growth owing to several key factors driving its expansion. Montelukast Sodium, a leukotriene receptor antagonist, is primarily used to manage and prevent asthma symptoms and to relieve symptoms of allergic rhinitis. Its efficacy in treating these conditions has contributed significantly to the expansion of the global market. Additionally, the rise in the prevalence of asthma and allergic rhinitis cases worldwide has fueled the demand for Montelukast Sodium. As healthcare awareness continues to increase and diagnostic capabilities improve, more individuals are being diagnosed with these conditions, further boosting the market's growth.

Furthermore, the growing focus on research and development activities by pharmaceutical companies to expand the application of Montelukast Sodium is a significant driver of market growth. These efforts aim to explore its potential in treating other respiratory conditions, such as exercise-induced bronchoconstriction and chronic obstructive pulmonary disease (COPD), thus widening its market scope. Additionally, the increasing adoption of Montelukast Sodium in pediatric populations, owing to its safety and efficacy profiles, has further propelled market expansion.

Moreover, the market is witnessing favorable regulatory approvals for Montelukast Sodium formulations in various regions, which have facilitated its widespread availability and contributed to market growth. The emergence of generic versions of Montelukast Sodium has also played a crucial role in expanding market penetration, particularly in developing regions where affordability and accessibility are key concerns.

In terms of regional analysis, North America currently holds a significant share of the Montelukast Sodium market, primarily attributed to the high prevalence of asthma and allergic rhinitis in the region and the presence of established healthcare infrastructure. However, the Asia-Pacific region is anticipated to exhibit substantial growth opportunities during the forecast period. Factors such as the rising healthcare expenditure, increasing awareness about respiratory diseases, and the expanding patient population in countries like China and India are expected to drive market growth in this region.

Montelukast Sodium Market Report Highlights

Montelukast sodium amorphous segment accounted for largest share in 2023, owing to its widespread use to prevent respiratory diseases with greater efficacy

Tablets segment held the maximum share in 2023, that is attributed to its numerous benefits including easy transportation, accurate dosage, and low chance of contamination

Asthma segment led the market in 2023, due to growing incidences of asthma worldwide and awareness among people about the available treatment options of disease

North America dominated the global market in 2023, on account of rising prevalence of respiratory conditions and growing research activities to discover new uses

The key market players include Sandoz International, Sun Pharmaceutical Industries, Merck, Cipla, and Aurobindo Pharma

Polaris Market Research has segmented the montelukast sodium market report based on product type, dosage form, application, and region:

Montelukast Sodium, Product Type Outlook (Revenue - USD Million, 2023 - 2032)

  • Montelukast Sodium Amorphous
  • Montelukast Sodium Crystalline

Montelukast Sodium, Dosage Form Outlook (Revenue - USD Million, 2023 - 2032)

  • Tablets
  • Chewable Tablets
  • Oral Solutions

Montelukast Sodium, Application Outlook (Revenue - USD Million, 2023 - 2032)

  • Asthma
  • Allergic Rhinitis Urticaria
  • Others

Montelukast Sodium, Regional Outlook (Revenue - USD Million, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Montelukast Sodium Market Insights

  • 4.1. Montelukast Sodium Market - Application Snapshot
  • 4.2. Montelukast Sodium Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing geriatric population to drive market growth
      • 4.2.1.2. Change in dietary habits and rapid urbanization to spur market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Side effects associated with montelukast
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Montelukast Sodium Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Montelukast Sodium Market, by Dosage Form

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • 5.3. Tablets
    • 5.3.1. Global Montelukast Sodium Market, by Tablets, by Region, 2019-2032 (USD Million)
  • 5.4. Chewable Tablets
    • 5.4.1. Global Montelukast Sodium Market, by Chewable Tablets, by Region, 2019-2032 (USD Million)
  • 5.5. Oral Solutions
    • 5.5.1. Global Montelukast Sodium Market, by Oral Solutions, by Region, 2019-2032 (USD Million)

6. Global Montelukast Sodium Market, by Product Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • 6.3. Montelukast Sodium Amorphous
    • 6.3.1. Global Montelukast Sodium Market, by Montelukast Sodium Amorphous, by Region, 2019-2032 (USD Million)
  • 6.4. Montelukast Sodium Crystalline
    • 6.4.1. Global Montelukast Sodium Market, by Montelukast Sodium Crystalline, by Region, 2019-2032 (USD Million)

7. Global Montelukast Sodium Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • 7.3. Asthma
    • 7.3.1. Global Montelukast Sodium Market, by Asthma, By Region, 2019-2032 (USD Million)
  • 7.4. Allergic Rhinitis Urticaria
    • 7.4.1. Global Montelukast Sodium Market, by Allergic Rhinitis Urticaria, By Region, 2019-2032 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Montelukast Sodium Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Montelukast Sodium Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Montelukast Sodium Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Montelukast Sodium Market - North America
    • 8.3.1. North America: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
    • 8.3.2. North America: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
    • 8.3.3. North America: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.3.4. Montelukast Sodium Market - U.S.
      • 8.3.4.1. U.S.: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.3.5. Montelukast Sodium Market - Canada
      • 8.3.5.1. Canada: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • 8.4. Montelukast Sodium Market - Europe
    • 8.4.1. Europe: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
    • 8.4.3. Europe: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.4. Montelukast Sodium Market - UK
      • 8.4.4.1. UK: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.5. Montelukast Sodium Market - France
      • 8.4.5.1. France: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.4.5.3. France: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.6. Montelukast Sodium Market - Germany
      • 8.4.6.1. Germany: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.7. Montelukast Sodium Market - Italy
      • 8.4.7.1. Italy: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.8. Montelukast Sodium Market - Spain
      • 8.4.8.1. Spain: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.9. Montelukast Sodium Market - Netherlands
      • 8.4.9.1. Netherlands: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.4.10. Montelukast Sodium Market - Russia
      • 8.4.10.1. Russia: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • 8.5. Montelukast Sodium Market - Asia Pacific
    • 8.5.1. Asia Pacific: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.4. Montelukast Sodium Market - China
      • 8.5.4.1. China: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.5.4.3. China: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.5. Montelukast Sodium Market - India
      • 8.5.5.1. India: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.5.5.3. India: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.6. Montelukast Sodium Market - Malaysia
      • 8.5.6.1. Malaysia: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.7. Montelukast Sodium Market - Japan
      • 8.5.7.1. Japan: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.8. Montelukast Sodium Market - Indonesia
      • 8.5.8.1. Indonesia: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.5.9. Montelukast Sodium Market - South Korea
      • 8.5.9.1. South Korea: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • 8.6. Montelukast Sodium Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.6.4. Montelukast Sodium Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.6.5. Montelukast Sodium Market - UAE
      • 8.6.5.1. UAE: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.6.6. Montelukast Sodium Market - Israel
      • 8.6.6.1. Israel: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.6.7. Montelukast Sodium Market - South Africa
      • 8.6.7.1. South Africa: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • 8.7. Montelukast Sodium Market - Latin America
    • 8.7.1. Latin America: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.7.4. Montelukast Sodium Market - Mexico
      • 8.7.4.1. Mexico: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.7.5. Montelukast Sodium Market - Brazil
      • 8.7.5.1. Brazil: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
    • 8.7.6. Montelukast Sodium Market - Argentina
      • 8.7.6.1. Argentina: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Apotex Inc. (Canada)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. .Aurobindo Pharma Ltd. (India)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Cipla Ltd. (India)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Glenmark Pharmaceutical Ltd. (India)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Jubilant Life Sciences Ltd. (India)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Merck & Co. Inc. (US)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mylan N.V. (US)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Sandoz International GmbH (Germany)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sun Pharmaceutical Industries Ltd. (India)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Teva Pharmaceutical Industries Ltd. (Israel)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 2 Global Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 3 Global Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 4 Montelukast Sodium Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 6 North America: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 7 North America: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 8 U.S.: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 9 U.S.: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 10 U.S.: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 11 Canada: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 12 Canada: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 13 Canada: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 14 Europe: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 15 Europe: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 16 Europe: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 17 UK: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 18 UK: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 19 UK: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 20 France: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 21 France: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 22 France: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 23 Germany: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 24 Germany: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 25 Germany: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 26 Italy: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 27 Italy: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 28 Italy: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 29 Spain: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 30 Spain: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 31 Spain: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 32 Netherlands: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 33 Netherlands: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 34 Netherlands: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 35 Russia: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 36 Russia: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 37 Russia: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 41 China: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 42 China: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 43 China: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 44 India: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 45 India: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 46 India: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 47 Malaysia: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 48 Malaysia: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 49 Malaysia: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 50 Japan: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 51 Japan: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 52 Japan: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 53 Indonesia: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 54 Indonesia: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 55 Indonesia: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 56 South Korea: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 57 South Korea: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 58 South Korea: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 65 UAE: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 66 UAE: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 67 UAE: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 68 Israel: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 69 Israel: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 70 Israel: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 71 South Africa: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 72 South Africa: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 73 South Africa: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 74 Latin America: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 75 Latin America: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 76 Latin America: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 77 Mexico: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 78 Mexico: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 79 Mexico: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 80 Brazil: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 81 Brazil: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 82 Brazil: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)
  • Table 83 Argentina: Montelukast Sodium Market, by Dosage Form, 2019-2032 (USD Million)
  • Table 84 Argentina: Montelukast Sodium Market, by Product Type, 2019-2032 (USD Million)
  • Table 85 Argentina: Montelukast Sodium Market, by Application, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Montelukast Sodium Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product Type
  • Figure 7. Global Montelukast Sodium Market, by Product Type, 2022 & 2032 (USD Million)
  • Figure 8. Market by Dosage Form
  • Figure 9. Global Montelukast Sodium Market, by Dosage Form, 2022 & 2032 (USD Million)
  • Figure 10. Market by Application
  • Figure 11. Global Montelukast Sodium Market, by Application, 2022 & 2032 (USD Million)
  • Figure 12. Montelukast Sodium Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Montelukast Sodium Market